Tetracaine (Ametop) Compared to Placebo for Reducing Pain Associated With Intramuscular Injection of Palivizumab (Synagis)

References 

1. Anand KJS International Evidence-Based Group for Neonatal Pain. Consensus statement for the prevention and management of pain in the newborn. Archives of Pediatrics and Adolescent Medicine. 2001;155:173–180
2. BC Centre for Disease Control . Communicable disease control immunization program, section IIA—immunization schedules, schedule A—basic immunization when starting with Pediacel vaccine. Retrieved June 25, 2009, from http://www.bccdc.ca/NR/rdonlyres/8CBF9E71-D186-4549-91CC-239E94D326F8/0/SectionIIA_June.pdf2009;
3. Carbajal R, Biran V, Lenclen R, Epaud R, Cimerman P, Thibault P, et al. EMLA cream and nitrous oxide to alleviate pain induced by palivizumab (Synagis) intramuscular injections in infants and young children. Pediatrics. 2008;121:e1591–e1598
   • CrossRef
4. Coleman MM, Solarin K, Smith C. Assessment and management of pain and distress in the neonate. Advances in Neonatal Care. 2002;2:123–139
5. Halperin BA, Halperin SA, McGrath P, Smith B, Houston T. Use of lidocaine–prilocaine patch to decrease intramuscular pain does not adversely affect the antibody response to diphtheria–tetanus–acellular pertussis-inactivated poliovirus–haemophilus influenzae type b conjugate and hepatitis b vaccines in infants from birth to six months of age. Pediatric Infectious Disease Journal. 2002;21:399–405
6. Jacobson RM, Swan A, Adegbenro A, Ludington SL, Wollan PC, Poland GA, et al. Making vaccines more acceptable—Methods to prevent and minimize pain and other common adverse events associated with vaccines. Vaccine. 2001;19:2418–2427
   • MEDLINE
   • CrossRef
7. Lacey CM, Finkelstein M, Thygeson MV. The impact of positioning on fear during immunizations: Supine versus sitting up. Journal of Pediatric Nursing. 2008;23:195–200
   • Abstract
   • Full Text
   • Full-Text PDF (119 KB)
   • CrossRef
8. Merkel SI, Voepel-Lewis T, Shayevitz JR, Malviya S. The FLACC: A behavioural scale for scoring postoperative pain in young children. Pediatric Nursing. 1997;23:293–297
   • MEDLINE
9. Meyerhoff AS, Weniger BG, Jacobs RJ. Economic value to parents of reducing the pain and emotional distress of childhood vaccine injections. Pediatric Infectious Disease Journal. 2001;20:S57–S62
10. Murtagh JE. Managing painful paediatric procedures. Australian Prescriber. 2006;29:94–96
11. O'Brien L, Taddio A, Ipp M, Goldbach M, Koren G. Topical 4% amethocaine gel reduces the pain of subcutaneous measles mumps and rubella vaccination. Pediatrics. 2004;114:720–724
    • CrossRef
12. O'Brien L, Taddio A, Lyszkiewicz DA, Koren G. A critical review of the topical local anesthetic amethocaine (Ametop) for pediatric pain. Pediatric Drugs. 2005;7:41–54
    • MEDLINE
    • CrossRef
13. Schechter NL. From the ouchless place to comfort central: The evolution of a concept. Pediatrics. 2008;122:S154–S160
    • CrossRef
14. Schechter NL, Zempsky WT, Cohen LL, McGrath PJ, McMurtry CM, Bright NS. Pain reduction during pediatric immunizations: Evidence-based review and recommendations. Pediatrics. 2007;119:e1184–e1198
    • CrossRef
15. Weisman SJ, Bernstein B, Schechter NL. Consequences of inadequate analgesia during painful procedures in children. Archives of Pediatrics and Adolescent Medicine. 1998;152:147–149
16. World Health Organization . Immunization. Retrieved March 2, 2009, from http://www.who.int/topics/immunization/en/2009;
17. World Health Organization . Respiratory syncytial virus and parainfluenza viruses. Retrieved March 2, 2009, from http://www.who.int/vaccine_research/diseases/ari/en/index2.html2009;
18. World Health Organization. Department of Immunization, Vaccines, and Biologicals . Immunization, vaccines, and biologicals. Retrieved March 2, 2009, from http://www.who.int/immunization/en/2009;